49 related articles for article (PubMed ID: 29214884)
1. Image-Based Modeling of Drug Delivery during Intraperitoneal Chemotherapy in a Heterogeneous Tumor Nodule.
Rezaeian M; Heidari H; Raahemifar K; Soltani M
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894436
[TBL] [Abstract][Full Text] [Related]
2. Correction to: PTEN-induced kinase 1 gene single-nucleotide variants as biomarkers in adjuvant chemotherapy for colorectal cancer: a retrospective study.
Mihara Y; Hirasaki M; Horita Y; Fujino T; Fukushima H; Kamakura Y; Uranishi K; Hirano Y; Ryozawa S; Yasuda M; Makino Y; Shibazaki S; Hamaguchi T
BMC Gastroenterol; 2023 Oct; 23(1):373. PubMed ID: 37907839
[No Abstract] [Full Text] [Related]
3. Dual Roles of Ascidian Chondromodulin-1: Promoting Cell Proliferation Whilst Suppressing the Growth of Tumor Cells.
Dou X; Li X; Yu H; Dong B
Mar Drugs; 2018 Feb; 16(2):. PubMed ID: 29439497
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal paclitaxel combined with FOLFOX/CAPOX plus bevacizumab for colorectal cancer with peritoneal carcinomatosis (the iPac-02 trial): study protocol of a single arm, multicenter, phase 2 study.
Murono K; Yokoyama Y; Nozawa H; Sasaki K; Emoto S; Matsuzaki H; Kashiwabara K; Ishigami H; Gohda Y; Yamaguchi H; Kitayama J; Ishihara S
Int J Colorectal Dis; 2023 Jun; 38(1):173. PubMed ID: 37340243
[TBL] [Abstract][Full Text] [Related]
5. Safety of intraperitoneal paclitaxel combined with conventional chemotherapy for colorectal cancer with peritoneal carcinomatosis: a phase I trial.
Murono K; Nagata H; Ishimaru K; Emoto S; Kaneko M; Hiyoshi M; Sasaki K; Otani K; Shuno Y; Nishikawa T; Tanaka T; Hata K; Kawai K; Nozawa H; Muro K; Ishihara S
Cancer Chemother Pharmacol; 2019 Jan; 83(1):145-150. PubMed ID: 30386886
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Early Postoperative Intraperitoneal Chemotherapy After Complete Surgical Resection of Peritoneal Metastasis from Colorectal Cancer: A Case-Control Study from a Single Center.
Park SY; Choi GS; Park JS; Kim HJ; Yang CS; Kim JG; Kang BW
Ann Surg Oncol; 2016 Jul; 23(7):2266-73. PubMed ID: 26951148
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant intraperitoneal chemotherapy for the treatment of colorectal cancer at risk for peritoneal carcinomatosis: a systematic review.
Feingold PL; Klemen ND; Kwong MLM; Hashimoto B; Rudloff U
Int J Hyperthermia; 2018 Aug; 34(5):501-511. PubMed ID: 29214884
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: A systematic review.
Feingold PL; Kwong ML; Davis JL; Rudloff U
J Surg Oncol; 2017 Feb; 115(2):192-201. PubMed ID: 27878811
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review.
Sloothaak DA; Mirck B; Punt CJ; Bemelman WA; van der Bilt JD; D'Hoore A; Tanis PJ
Br J Cancer; 2014 Sep; 111(6):1112-21. PubMed ID: 25025964
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
